Charles & Colvard Appoints Don O’Connell as President and Chief Executive Officer
RESEARCH TRIANGLE PARK, N.C., May 29, 2020 (GLOBE NEWSWIRE) — Charles & Colvard, Ltd. (Nasdaq: CTHR), (the “Company”), the original […]
CytomX Therapeutics Clinical Programs Highlighted at American Society of Clinical Oncology ASCO20 Virtual Scientific Program
– First Presentation of Clinical Data for CX-2029, a Probody Drug Conjugate, Directed Against CD71: A Previously Undruggable Target –– Data […]
Iovance Presents Updated Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy Lifileucel in Advanced Melanoma at ASCO Scientific Program
Median Duration of Response Not Reached at 18.7 Months of Median Study Follow Up36.4% Overall Response Rate (ORR) MaintainedSAN CARLOS, […]
Bio-Path Holdings Presents at 2020 American Society of Clinical Oncology Annual Meeting
HOUSTON, May 29, 2020 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense […]
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
– Shares of combined company to commence trading on Nasdaq Global Market under the symbol “LRMR” on May 29, 2020– […]
BeiGene Presents Updated Head to Head Results from Phase 3 Trial of Zanubrutinib vs. Ibrutinib in Patients with Waldenström’s Macroglobulinemia at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program
– Additional follow-up in Phase 3 ASPEN trial continued to show clinically meaningful safety and tolerability advantages for zanubrutinib compared […]
electroCore, Inc. to Present at Little Grapevine’s G1 Microcap Virtual Conference
BASKING RIDGE, N.J., May 29, 2020 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that […]
RAPT Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology Virtual Scientific Program
SOUTH SAN FRANCISCO, Calif., May 29, 2020 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused […]
Candente Gold Advances new Growth Strategy
VANCOUVER, British Columbia, May 29, 2020 (GLOBE NEWSWIRE) — Candente Gold Corp. (TSXV:CDG) (“Candente Gold” and/or the “Company”) is pleased […]
Feronia Inc. Advises on Timing of Filing Interim Financial Statements and Management’s Discussion and Analysis
TORONTO, May 29, 2020 (GLOBE NEWSWIRE) — Feronia Inc. (“Feronia” or the “Company”) (TSX-V: FRN) today provides an update on […]
